Page 5,331«..1020..5,3305,3315,3325,333..5,3405,350..»

Autism Treatment UK: Complimentary Webinar The Son-Rise Program Techniques from Raun K. Kaufman 16.5 – Video

Posted: Published on May 10th, 2013

Autism Treatment UK: Complimentary Webinar The Son-Rise Program Techniques from Raun K. Kaufman 16.5 http://www.autismtreatment.org/ Raun K. Kaufman, the Global Director of Education for the Autism Treatment Center of America trade;, will be giving a free 90-minut... By: autismtreatment … Continue reading

Comments Off on Autism Treatment UK: Complimentary Webinar The Son-Rise Program Techniques from Raun K. Kaufman 16.5 – Video

Providence Health Plan sued over autism treatment coverage

Posted: Published on May 10th, 2013

by Rich Kurz kgw.com Posted on May 9, 2013 at 6:15 AM Updated today at 6:10 PM PORTLAND -- A Portland family that has a child with autism is suing health insurance provider Providence Health Plan after the family says the plan denied them a doctor-recommended therapy. Today, Lucia Alonsos 6-year-old son is talking and going to school. It didnt always seem so hopeful. At 14 months, she says he stopped using the few words he knew and avoided eye contact. Her sons doctor recommended a treatment called ABA, or Applied Behavior Analysis. Alonso credits that treatment for helping to slowly bring back her sons social interaction. Theres one big problemshe cant pay for it. "Everyday people like us cant afford to spend three to four hundred a week on therapy, Alonso said. She says her insurer, Providence Health Plan, repeatedly denied her coverage for the ABA sessions. After consulting with other parents who faced the same struggle she decided to hire a lawyer and file a class action lawsuit in U.S. District Court. View original post here: Providence Health Plan sued over autism treatment coverage … Continue reading

Comments Off on Providence Health Plan sued over autism treatment coverage

Acute Heart Stroke Treated by Dr. Sharath Reddy, Best Cardiologist in Hyderabad – Video

Posted: Published on May 10th, 2013

Acute Heart Stroke Treated by Dr. Sharath Reddy, Best Cardiologist in Hyderabad This video is about experience of a patient who was suffering from chest pain and got treatment at Sunshine Hospitals, best hospital in Hyderabad. Mr. Surend... By: SunshineHospital … Continue reading

Comments Off on Acute Heart Stroke Treated by Dr. Sharath Reddy, Best Cardiologist in Hyderabad – Video

Julius David Stroke Treatment – Video

Posted: Published on May 10th, 2013

Julius David Stroke Treatment Blood Bank Project - High Tech High Class of 2008 Blair Hatch and Jeff Robin Physiology and Art. By: mmHTH … Continue reading

Comments Off on Julius David Stroke Treatment – Video

Act FAST for Stroke Awareness Month in May

Posted: Published on May 10th, 2013

Belleville, IL (PRWEB) May 10, 2013 Every 40 seconds, someone in the U.S. has a stroke. Allsup, a nationwide provider of Social Security Disability Insurance (SSDI) representation, veterans disability appeal and Medicare plan selection services is pleased to sponsor the National Stroke Associations Act FAST for Stroke Challenge to help raise awareness and funds. A stroke happens when blood flow to a part of the brain stops, depriving it of oxygen and killing brain cells. Permanent brain damage can result. Stroke is a leading cause death and disability, causing paralysis, speech difficulties, muscle and nerve problems, cognitive difficulties and other disabling conditions. Lack of awareness of stroke signs and symptoms among the general public is a huge challenge, said Jim Baranski, CEO of the National Stroke Association. National Stroke Awareness Month is a great opportunity to work together to raise support and awareness in the community. The National Stroke Association encourages the public to act and think FAST when it comes to stroke. The sooner an individual gets emergency medical treatment, the better their odds are for survival and recovery. Face: Ask the person to smile. Does one side of the face droop? Arms: Ask the person to raise both … Continue reading

Comments Off on Act FAST for Stroke Awareness Month in May

Acorda Therapeutics Announces Data Showing Dalfampridine Improves Motor Function in Preclinical Model of Post-Stroke …

Posted: Published on May 10th, 2013

ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that data showing treatment with dalfampridine improved motor function in a preclinical model of post-stroke deficits have been published online ahead of print on May 7th in Stroke, a peer-reviewed journal of the American Heart Association. The data will be included in the July 2013 print edition of Stroke. Dalfampridine is the active ingredient in AMPYRA (dalfampridine) Extended Release Tablets, 10 mg. These preclinical data showed that dalfampridine can improve motor function long after a stroke, when the natural recovery process has ended and stable deficits are likely to persist over time. The results informed our decision to conduct a recently completed proof-of-concept study in humans, which indicated that dalfampridine improved walking in people with post-stroke deficits, said Andrew R. Blight, Ph.D., Acorda Therapeutics Chief Scientific Officer. More than half of the nearly seven million people in the United States who live with the long term effects of a stroke have lasting mobility impairment, but there are no established treatments other than physical therapy to address these impairments. New therapies are needed, and we are moving forward with development of dalfampridine extended release tablets in this indication. The paper, entitled … Continue reading

Comments Off on Acorda Therapeutics Announces Data Showing Dalfampridine Improves Motor Function in Preclinical Model of Post-Stroke …

Tech Offers Web of Support for Stroke Survivors

Posted: Published on May 10th, 2013

Every few years, we see breakthroughs in the medical and health community, as well as in the wireless and telecom industry. We are just in the early stages of a technology revolution that will help stroke survivors. Visit the iTunes App Store or Google Play and take a look. Believe it or not, today there are stroke apps. Yes that's right, there's an app for that -- several of them as a matter of fact. May is National Stroke Awareness month. I like to follow the technology advancements for stroke prevention and treatment -- and the companies making them -- because I have been a stroke survivor for nine years. We don't realize it on a daily basis, but things advance as quickly in the medical and health industries as in wireless and communications. If I had my stroke today rather than nine years ago, there would be much more help at my fingertips. My stroke occurred in 2004. As advanced as the medical community had become by then, it was very distant from where it is today. Doctors struggled with too many questions and offered me very few answers. They simply didn't know. Plus, they were not counselors, so … Continue reading

Comments Off on Tech Offers Web of Support for Stroke Survivors

Acorda Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Posted: Published on May 10th, 2013

ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Andrew R. Blight, Ph.D., Acordas Chief Scientific Officer will present at the Bank of America Merrill Lynch 2013 Health Care Conference on Thursday, May 16 at 10:40 a.m. at the Encore at the Wynn Las Vegas Hotel in Las Vegas, Nevada. A live audio webcast of the presentation can be accessed under Investor Events in the Investor section of the Acorda website at http://www.acorda.com or you may use the link: http://www.veracast.com/webcasts/baml/healthcare2013/id38106640.cfm Please log in approximately 5 minutes before the scheduled time of the presentations to ensure a timely connection. Archived versions of this webcast will be available until April 4 on the Investors section of http://www.acorda.com. About Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with MS, spinal cord injury and other neurological conditions. Acorda markets AMPYRA (dalfampridine) Extended Release Tablets, 10 mg, in the United States as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an improvement in walking speed. AMPYRA is marketed outside the United States as FAMPYRA (prolonged-release fampridine tablets) by Biogen Idec under a licensing … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Acorda Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Caution urged on antibiotic cure to back pain

Posted: Published on May 10th, 2013

Antibiotics were touted in headlines this week as a groundbreaking treatment for chronic lower back pain. The Guardian quoted a prominent British spinal surgeon as saying the experimental treatment, based on Danish research, is worthy of a Nobel Prize. But Canadian specialists in spinal-cord injury caution that the promise of an antibiotic cure is based on a preliminary pilot study that is far from conclusive. According to the study, published in April in the European Spine Journal, as many as four in 10 cases of chronic lower back pain may be caused by a bacterial infection that can be cleared up with antibiotics. Researchers from the Spine Centre of Southern Denmark recruited 162 patients who had suffered lower back pain for at least six months following a herniated disc. The patients also had a type of swelling within the vertebrae known as Modic Type 1 changes. Patients received either 100 days of antibiotic treatment or a placebo. Compared with patients given a placebo, the treatment group improved significantly in measures of pain and use of sick leave. The improvements persisted in a one-year follow-up. In an earlier report, also published in the European Spine Journal, the Danish team linked Modic … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Caution urged on antibiotic cure to back pain

InVivo Therapeutics Reports First Quarter 2013 Financial Results, Provides Business Update

Posted: Published on May 10th, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today reported financial results for the three months ended March 31, 2013 and provided a business update. InVivo has pioneered a new treatment platform utilizing a variety of biocompatible polymer-based devices to provide structural support to a damaged spinal cord in order to spare tissue from scarring while improving functional recovery and prognosis after a traumatic spinal cord injury. Today there is no effective treatment for the spinal cord for paralysis caused by SCIs, and the market potential is estimated to be over $15 billion. "We are off to a great start for 2013 and continue to successfully accelerate our plans, said Frank Reynolds, InVivos Chief Executive Officer. Weve received FDA approval to commence a first-in- man clinical study for our biopolymer scaffolding to treat acute SCI, and we also received Humanitarian Use Device designation for the product. Wall Street has noticed, and our stock price has appreciated significantly since these key milestones were achieved. This has permitted us to call investor warrants that will provide up to $16.1 million of equity capital, but more … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on InVivo Therapeutics Reports First Quarter 2013 Financial Results, Provides Business Update

Page 5,331«..1020..5,3305,3315,3325,333..5,3405,350..»